Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 44: 858-862, 1998;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (30)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huengsberg, M.
Right arrow Articles by Shahmanesh, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huengsberg, M.
Right arrow Articles by Shahmanesh, M.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Nutrition
(Clinical Chemistry. 1998;44:858-862.)
© 1998 American Association for Clinical Chemistry, Inc.

General Clinical Chemistry

Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients

Mia Huengsberg1,a, John B. Winer2, Mark Gompels3, Rachel Round1, Jonathan Ross1, and Mohsen Shahmanesh1

1 Department of GU Medicine, Whittall Street Clinic, Birmingham B4-6 DH, UK.

2 Department of Neurology, University Hospital Birmingham NHS Trust, Birmingham B15-2 TH, UK.

3 Department of Immunology, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK.
a Address correspondence to this author at: Department of GU Medicine, Whittall Street Clinic, Birmingham, B4 6DH, UK. Fax 44-121-237-5729; e-mail: Mia{at}di-ren.demon.co.uk.

An alternative pathway of Trp metabolism involves the conversion of Trp to kynurenine by indoleamine-2,3-dioxygenase, which leads to synthesis of the neurotoxin, quinolinic acid. This study explores the relationship of indoleamine-2,3-dioxygenase activity with stages of HIV infection. Sera from 206 HIV-positive and 72 seronegative subjects were analyzed for Trp and kynurenine. The kynurenine-to-Trp (KT) ratio was calculated. The mean KT ratio of seronegative controls was 36.6 ± 10.9, and the median ratio was 34.9. The upper limit of the seronegative KT ratio, defined as mean + 2 SD, was 58.4. Patients with HIV infection showed a reciprocal relationship between the KT ratio, the CD4 count, and the stage of the disease. The median KT ratios for asymptomatic and AIDS patients were 50.5 and 117.0, respectively. This study shows that the serum Trp concentration is markedly decreased and that the kynurenine concentration is increased with immune stimulation in HIV infection. This may lead to changes in quinolinic acid and explain some of the pathogenesis of AIDS dementia.




The following articles in journals at HighWire Press have cited this article:


Home page
 BloodHome page
A. Boasso, J.-P. Herbeuval, A. W. Hardy, S. A. Anderson, M. J. Dolan, D. Fuchs, and G. M. Shearer
HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells
Blood, April 15, 2007; 109(8): 3351 - 3359.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
B. Maneglier, C. Rogez-Kreuz, P. Cordonnier, P. Therond, C. Advenier, D. Dormont, P. Clayette, and O. Spreux-Varoquaux
Simultaneous Measurement of Kynurenine and Tryptophan in Human Plasma and Supernatants of Cultured Human Cells by HPLC with Coulometric Detection
Clin. Chem., November 1, 2004; 50(11): 2166 - 2168.
[Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
B. Wirleitner, D. Reider, S. Ebner, G. Bock, B. Widner, M. Jaeger, H. Schennach, N. Romani, and D. Fuchs
Monocyte-derived dendritic cells release neopterin
J. Leukoc. Biol., December 1, 2002; 72(6): 1148 - 1153.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
P. Terness, T. M. Bauer, L. Rose, C. Dufter, A. Watzlik, H. Simon, and G. Opelz
Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase-expressing Dendritic Cells: Mediation of Suppression by Tryptophan Metabolites
J. Exp. Med., August 19, 2002; 196(4): 447 - 457.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Laich, G. Neurauter, B. Widner, and D. Fuchs
More Rapid Method for Simultaneous Measurement of Tryptophan and Kynurenine by HPLC
Clin. Chem., March 1, 2002; 48(3): 579 - 581.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Association for Clinical Chemistry.